Year archive

BLINKLAB LIMITED — 2025 filings

All 80 regulatory filings released by BLINKLAB LIMITED (BB1) in 2025, sourced directly from the official regulator.

80 Filings

2025 Period

2025 filings (80)

Filing	Released	Lang
Final Director's Interest Notice 2 pages 224.0KB Director's Dealing	2025-12-18	English
Initial Director's Interest Notice 2 pages 265.5KB Director's Dealing	2025-12-18	English
Appointment of Managing Director and Board Changes 4 pages 267.1KB Board/Management Information	2025-12-17	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-12-03	English
Section 708A Notice 1 page 163.4KB Regulatory Filings	2025-12-03	English
Updated Corporate Presentation 25 pages 8.7MB Investor Presentation	2025-12-01	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-11-25	English
Section 708A Notice 1 page 163.4KB Regulatory Filings	2025-11-25	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-11-18	English
Section 708A Notice 1 page 170.2KB Regulatory Filings	2025-11-18	English
Rush University Medical Center joins Pivotal US Autism Trial 4 pages 317.8KB Regulatory Filings	2025-11-12	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-11-09	English
Section 708A Notice 1 page 169.3KB Regulatory Filings	2025-11-09	English
Results of Annual General Meeting 2 pages 129.3KB Declaration of Voting Results & Voting Rights Announcements	2025-11-06	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 802.2KB Interim / Quarterly Report	2025-10-28	English
Pilot Study Confirms High Diagnostic Accuracy & Readiness 8 pages 359.5KB Capital/Financing Update	2025-10-21	English
Investor Webinar 2 pages 136.0KB Investor Presentation	2025-10-21	English
Trading Halt 2 pages 212.1KB Regulatory Filings	2025-10-19	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-10-14	English
Section 708A Notice 1 page 169.3KB Regulatory Filings	2025-10-14	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-10-13	English
Section 708A Notice 1 page 196.2KB Regulatory Filings	2025-10-13	English
Notice of AGM & Proxy Form 21 pages 465.6KB AGM Information	2025-09-21	English
Letter to Shareholders & Proxy Form 3 pages 207.2KB AGM Information	2025-09-21	English
The Vanderbilt Kennedy Center Onboarded 4 pages 558.4KB Regulatory Filings	2025-09-17	English
The University of Missouri - Thompson Center - Engaged 4 pages 517.0KB Regulatory Filings	2025-09-16	English
Date of AGM & Closing Date for Director Nominations 1 AGM Information	2025-09-10	English
2025 Annual Report & Appendix 4E 62 pages 1.7MB Annual Report	2025-08-27	English
Appendix 4G & Corporate Governance Statement 32 pages 765.7KB Governance Information	2025-08-27	English
Two Additional Strategic Partnerships Advance FDA Submission 4 pages 541.9KB Capital/Financing Update	2025-08-25	English
University of Pennsylvania Perelman School of Med Onboarded 3 pages 305.3KB Regulatory Filings	2025-08-20	English
Presentation - TechKnow Invest Roadshow Conference 27 pages 8.7MB Investor Presentation	2025-08-18	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-08-12	English
Section 708A Notice 1 page 116.9KB Regulatory Filings	2025-08-12	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.0MB Interim / Quarterly Report	2025-07-24	English
Change of Director's Interest Notice x4 12 pages 4.5MB Director's Dealing	2025-07-10	English
Application for quotation of securities - BB1 6 pages 19.0KB Regulatory Filings	2025-07-08	English
Notification regarding unquoted securities - BB1 6 pages 20.8KB Share Issue/Capital Change	2025-07-08	English
Notification regarding unquoted securities - BB1 7 pages 22.2KB Share Issue/Capital Change	2025-07-08	English
Section 708A Notice 1 page 364.9KB Regulatory Filings	2025-07-08	English
UNMC Engaged as Second Site in Main Phase of FDA510(k) Study 2 pages 284.0KB Capital/Financing Update	2025-07-07	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-07-01	English
Section 708A Notice 1 page 462.7KB Regulatory Filings	2025-07-01	English
US Ethics Approval Received for the Main Phase of FDA510(k) 3 pages 373.1KB Regulatory Filings	2025-06-29	English
Application for quotation of securities - BB1 6 pages 18.4KB Share Issue/Capital Change	2025-06-29	English
Section 708A Notice 1 page 463.5KB Regulatory Filings	2025-06-29	English
Results of General Meeting 3 pages 225.0KB Declaration of Voting Results & Voting Rights Announcements	2025-06-29	English
Response to ASX Price and Volume Query 3 pages 757.0KB Regulatory Filings	2025-06-23	English
Change in substantial holding 2 pages 205.0KB Major Shareholding Notification	2025-06-19	English
Change in substantial holding 2 pages 204.3KB Major Shareholding Notification	2025-06-19	English
Ceasing to be a substantial holder 1 page 198.9KB Major Shareholding Notification	2025-06-18	English
Ceasing to be a substantial holder 1 page 199.6KB Major Shareholding Notification	2025-06-18	English
Notice of General Meeting & Proxy Form 40 pages 646.3KB Proxy Solicitation & Information Statement	2025-05-29	English
Letter to Shareholders & Proxy Form 3 pages 492.5KB AGM Information	2025-05-29	English
BlinkLab Engages First Clinical Site for Main Study Phase 4 pages 373.3KB Regulatory Filings	2025-05-21	English
Change of Director's Interest Notice (RH) 3 pages 1.2MB Director's Dealing	2025-05-19	English
Application for quotation of securities - BB1 6 pages 18.5KB Share Issue/Capital Change	2025-05-07	English
Section 708A Notice 1 page 462.4KB Regulatory Filings	2025-05-07	English
Successful Placement of A$7.66M to Underpin Growth Strategy 4 pages 447.3KB Capital/Financing Update	2025-04-30	English
Proposed issue of securities - BB1 6 pages 22.0KB Capital/Financing Update	2025-04-30	English
Trading Halt 2 pages 280.8KB Capital/Financing Update	2025-04-28	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.3MB Interim / Quarterly Report	2025-04-27	English
BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial 3 pages 379.8KB Regulatory Filings	2025-03-31	English
Pause in Trading 1 page 115.1KB Regulatory Filings	2025-03-30	English
Trading Halt 2 pages 282.1KB Regulatory Filings	2025-03-30	English
Brokers meet Biotech Presentation 36 pages 13.2MB Investor Presentation	2025-03-19	English
Blinklab Expands Autism Diagnostics into Adults 4 pages 312.1KB Regulatory Filings	2025-03-18	English
US Autism Diagnostic Study Commences with First Child Tested 3 pages 376.7KB Regulatory Filings	2025-03-11	English
Application for quotation of securities - BB1 6 pages 18.3KB Share Issue/Capital Change	2025-02-26	English
Section 708(A) Notice 1 page 476.4KB Capital/Financing Update	2025-02-26	English
Half Yearly Report and Accounts 23 pages 1.9MB Interim / Quarterly Report	2025-02-25	English
North Shore Pediatric Therapy in Chicago joins Study 3 pages 399.0KB Capital/Financing Update	2025-02-09	English
BlinkLab Initiates its First US-based Clinical Site 3 pages 402.2KB Regulatory Filings	2025-02-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.5MB Interim / Quarterly Report	2025-01-29	English
Change of Director's Interest Notice 3 pages 1.2MB Director's Dealing	2025-01-13	English
Change of Director's Interest Notice 3 pages 712.9KB Director's Dealing	2025-01-13	English
Change of Director's Interest Notice 3 pages 789.2KB Director's Dealing	2025-01-09	English
Change of Director's Interest Notice 3 pages 713.8KB Director's Dealing	2025-01-09	English
Change of Director's Interest Notice 3 pages 1.2MB Director's Dealing	2025-01-09	English
Change of Director's Interest Notice 3 pages 713.0KB Director's Dealing	2025-01-06	English